Markets

DENTSPLY (XRAY) Q2 Earnings Beat Estimates, Sales Rise Y/Y

DENTSPLY SIRONA Inc.XRAY is one of the leading worldwide manufacturers' dental consumables, dental laboratory products, dental specialty products and consumable medical device products. Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.

Currently, this York, PA- based company carries a Zacks Rank #4 (Sell) but that could change following its second quarter 2018 earnings report which has just released. (You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here .) We have highlighted some of the key details from the just-released announcement below:

Earnings: DENTSPLY reported adjusted earnings of 60 cents per share, which came above the Zacks Consensus Estimate by a penny and was higher than earnings of 65 cents in the year-ago quarter.

Revenues: DENTSPLY's net sales increased to $1.04 billion from $992.7 million in the year-ago period. Net sales increased 5% on a year over year basis.

This also came above the Zacks Consensus Estimate of $1.03 billion.

Net sales, excluding precious metals, increased 5.1% on a year over year basis to $1.03 billion.

DENTSPLY SIRONA Inc. Price and EPS Surprise

DENTSPLY SIRONA Inc. Price and EPS Surprise | DENTSPLY SIRONA Inc. Quote

Important Details: In the second quarter, DENTSPLY recorded a goodwill and intangible impairment charge of $1.27 billion. Of this charge, almost $1.20 billion was in the Technologies and Equipment segment.

The Consumable Segment suffered charges worth $69 million for impairment.

Narrowed Guidance: The company narrowed its adjusted EPS guidance for 2018 to the range of $2.00 to $2.15 per share. Earlier, the company projected adjusted EPS in a range of $2.55 to $2.65.

Share Price: Following the earnings release, share prices plunged 18.5% in the pre-market trading session.

Check back later for our full write up on this DENTSPLY earnings report later!

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce ""the world's first trillionaires,"" but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

XRAY

Other Topics

Earnings Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More